The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,321–1,344 of 11,281
ArticlePsychedelics

Attitudes and perceptions of psychedelic therapy among clinical trial participants with alcohol use disorder: a mixed-method study.

Kirsch J, Poppe C, Beck A +6

Europe PMC2026
ArticlePsychedelics

Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History.

Steinle JT, Shankar S, Siegel JS +7

Europe PMC2026
ProjectPsychedelics

Becoming a Psychedelic Therapist: A Professional Identity Journey

OSF2026
ArticlePsychedelics

An exploratory study of breathwork-induced altered states of consciousness in experienced practitioners: the airways to alteration (A2A) trial.

Fincham GW, Caddye E, Kartar AA +3

Europe PMC2026
ArticlePsilocybin

Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France : une étude transversale nationale.

Gillet M, Doudeau N, Vilain F +3

Europe PMC2026
TrialKetamine

Pharmacokinetics and Safety of Single-Dose Wafermine™ (Ketamine Sublingual Wafer) in Healthy Subjects

ClinicalTrials.gov2026
PreregistrationPsychedelics

Mental health practitioners' (MHPs') attitudes towards psychedelic-assisted therapy (PAT)

OSF2026
PreprintPsychedelics

Intentions might matter in unexpected ways: A nuanced exploration of psychedelic intentions beyond their type

Mosina I, Luke D

Europe PMC2026
ProjectPsychedelics

A prospective preregistered naturalistic study on Early Maladaptive Schemas After a Psychedelic Retreat Experience

OSF2026
TrialKetamine

The Effects of Different Anesthetics on the Brain's Neural Networks

ClinicalTrials.gov2026
PreprintLSD

One operator to rule them all: Unifying connectome harmonics, turbulence and complex harmonics in brain dynamics

Kringelbach ML, Deco G

Europe PMC2026
ArticlePsilocybin

Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.

Bhat A, Zolali E, Sakib MA +4

Europe PMC2026
ArticlePsilocybin

Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.

Pines AR, Zhang X, Kochalka J +8

Europe PMC2026
ArticleKetamine

Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance.

Li DJ, Hsu TW, Changchien TC +4

Europe PMC2026
TrialPsilocybin

Psilocybin-Assisted Therapy

ClinicalTrials.gov2026
ArticleKetamine

[Intravenous Subnarcotic Ketamine Infusions for Treatment-Resistant Depression: Historical Development, Comparison with Esketamine Nasalspray, and Prospects].

Bonnet U, Scherbaum N, Juckel G +1

Europe PMC2026
ArticleKetamine

Efficacy and safety of perioperative esketamine in improving postoperative sleep disturbances: A systematic review and meta-analysis.

Yang X, Gao T, Wang S +4

Europe PMC2026
ArticleKetamine

Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depression.

Benster LL, Kohn JN, Wade B +5

Europe PMC2026
ArticleKetamine

From psychache to neuroplasticity: A unified rescue-repair model of Ketamine's anti-suicidal action.

Domany Y, Solomon-Shashua A

Europe PMC2026
ArticleMDMA

Psychometric validation of the French version of the five-dimensional altered states of consciousness questionnaire (5D-ASC) and associated 11 OAV subscales.

Kervadec E, Mathieu P, Fauvel B +6

Europe PMC2026
PreprintPsychedelics

The Emperor's New Diagnoses: Psychedelics, Psychosis, and the Limits of Psychiatric Distinctions

Willard M

Europe PMC2026
ArticleKetamine

Perioperative interventions in preventing postoperative delirium following orthopaedic surgery in the elderly: a Bayesian network meta-analysis.

Cai X, Shen K, Xiong H +2

Europe PMC2026
ArticlePsilocybin

A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.

Graham M, Ge Y, Pacula RL +4

Europe PMC2026
ArticlePsilocybin

Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy.

Tarbi EC, Bhatia I, Balach N +10

Europe PMC2026